Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation
- 1 September 2003
- journal article
- website
- Published by Wiley in Transplant Infectious Disease
- Vol. 5 (3) , 132-139
- https://doi.org/10.1034/j.1399-3062.2003.00027.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseasesBlood, 2003
- High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic TransplantationClinical Infectious Diseases, 2003
- Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulinBone Marrow Transplantation, 2002
- Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimenBlood, 2002
- No Cytomegalovirus-related Deaths After Non-ablative Stem Cell AllograftsHematology, 2002
- Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 2001
- Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 2001
- High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationBone Marrow Transplantation, 2000
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989